Kathleen E Corey Selected Research

tesamorelin

1/2021	Clinical Predictors of Liver Fibrosis Presence and Progression in Human Immunodeficiency Virus-Associated Nonalcoholic Fatty Liver Disease.
1/2021	Growth Hormone Releasing Hormone Reduces Circulating Markers of Immune Activation in Parallel with Effects on Hepatic Immune Pathways in Individuals with HIV-infection and Nonalcoholic Fatty Liver Disease.
1/2021	Delineating tesamorelin response pathways in HIV-associated NAFLD using a targeted proteomic and transcriptomic approach.
1/2020	Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLD.
12/2019	Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kathleen E Corey Research Topics

Disease

52	Non-alcoholic Fatty Liver Disease 01/2022 - 11/2011
43	Fibrosis (Cirrhosis) 01/2022 - 01/2009
10	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2009
10	Liver Diseases (Liver Disease) 01/2022 - 01/2012
9	Inflammation (Inflammations) 01/2022 - 08/2015
9	Infections 01/2022 - 10/2006
9	Obesity 01/2022 - 01/2017
8	Hepatitis C 08/2020 - 10/2006
7	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 05/2009
6	Alcoholic Fatty Liver 01/2022 - 01/2013
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 10/2015
4	Fatty Liver 12/2019 - 01/2013
4	Morbid Obesity 01/2019 - 01/2016
4	Chronic Hepatitis C 01/2014 - 05/2009
3	Neoplasms (Cancer) 04/2022 - 11/2003
3	Overweight 01/2022 - 01/2017
3	HIV Infections (HIV Infection) 01/2021 - 12/2019
3	Disease Progression 01/2021 - 01/2012
3	End Stage Liver Disease 11/2019 - 01/2016
3	Weight Loss (Weight Reduction) 03/2017 - 01/2016
2	Myocardial Infarction 01/2021 - 07/2017
2	Esophageal Squamous Cell Carcinoma 01/2021 - 01/2019
2	Unstable Angina 01/2021 - 07/2017
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 01/2018
2	Hypertension (High Blood Pressure) 01/2021 - 05/2009
2	Insulin Resistance 01/2021 - 12/2016
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 10/2018
2	Obstructive Sleep Apnea 01/2017 - 01/2013
2	Dyslipidemias (Dyslipidemia) 12/2016 - 03/2015
1	Hepatitis 01/2022
1	Cicatrix (Scar) 01/2022
1	Diabetes Mellitus 01/2022
1	Carcinogenesis 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2021

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2012
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2019
5	tesamorelin FDA Link 01/2021 - 12/2019
4	LipidsIBA 01/2022 - 10/2009
4	Insulin-Like Growth Factor I (IGF-1)IBA 01/2022 - 01/2017
4	nasIBA 01/2021 - 08/2015
4	CholesterolIBA 01/2021 - 10/2009
4	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 05/2012
3	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2014
3	Growth Hormone (Somatotropin)IBA 01/2022 - 01/2017
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 10/2015
3	RNA (Ribonucleic Acid)IBA 10/2021 - 01/2021
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 12/2018
3	Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA 01/2021 - 01/2020
3	HDL CholesterolIBA 01/2021 - 06/2012
3	Antiviral Agents (Antivirals)IBA 08/2020 - 03/2011
3	Triglycerides (Triacylglycerol)IBA 01/2019 - 03/2015
2	EnzymesIBA 04/2022 - 10/2018
2	CollagenIBA 01/2022 - 07/2018
2	Metalloproteases (Metalloproteinases)IBA 01/2022 - 01/2020
2	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 10/2021
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022 - 03/2015
2	Transaminases (Aminotransferases)IBA 01/2021 - 02/2015
2	omega-Chloroacetophenone (Mace)IBA 01/2021 - 07/2017
2	Hormones (Hormone)IBA 01/2021 - 01/2021
2	InterleukinsIBA 01/2021 - 01/2017
2	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 03/2015
2	Messenger RNA (mRNA)IBA 01/2021 - 07/2018
2	Interleukin-18 (Interleukin 18)IBA 01/2021 - 08/2020
2	SofosbuvirIBA 08/2020 - 01/2015
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2019 - 06/2019
2	Alanine Transaminase (SGPT)IBA 06/2019 - 01/2016
2	ApolipoproteinsIBA 01/2019 - 05/2012
2	Lipoproteins (Lipoprotein)IBA 01/2019 - 06/2014
2	Ezetimibe (Zetia)FDA Link 11/2018 - 12/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 01/2017
2	Insulin (Novolin)FDA Link 01/2017 - 12/2016
2	Biological ProductsIBA 01/2017 - 12/2016
2	MicroRNAs (MicroRNA)IBA 01/2017 - 12/2015
2	Vitamin E FDA LinkGeneric 05/2016 - 03/2015
2	Epidermal Growth Factor (EGF)IBA 04/2016 - 01/2014
2	AlbuminsIBA 01/2016 - 01/2014
2	oxidized low density lipoproteinIBA 03/2015 - 10/2009
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 11/2011 - 01/2009
2	Ribavirin (Virazole)FDA LinkGeneric 09/2010 - 12/2007
1	DNA (Deoxyribonucleic Acid)IBA 04/2022
1	DNA Repair EnzymesIBA 04/2022
1	NADP (NADPH)IBA 04/2022
1	8-hydroxyguanineIBA 04/2022
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 01/2022
1	ThrombospondinsIBA 01/2022
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2022
1	Atorvastatin (Lipitor)FDA Link 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	DisintegrinsIBA 01/2022
1	Peptides (Polypeptides)IBA 10/2021
1	Pharmaceutical PreparationsIBA 10/2021
1	ThiazolidinedionesIBA 01/2021
1	Nonesterified Fatty Acids (NEFA)IBA 01/2021

Therapy/Procedure

13	Therapeutics 04/2022 - 01/2009
10	Liver Transplantation 01/2022 - 11/2011
10	Bariatric Surgery 11/2021 - 01/2013
5	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2019 - 01/2016
3	Drug Therapy (Chemotherapy) 03/2017 - 03/2011
2	Palliative Care (Palliative Therapy) 11/2019 - 01/2019
2	Gastrectomy 01/2019 - 01/2016